HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis.

AuthorsRudolf Benz, Kathrin Zimmermann, Markus Rechsteiner, Stefan Balabanov, Markus G Manz, Corinne C Widmer
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 61 Issue 10 Pg. 2533-2535 (10 2020) ISSN: 1029-2403 [Electronic] United States
PMID32449412 (Publication Type: Letter)
Chemical References
  • Polyethylene Glycols
  • Interferons
Topics
  • Humans
  • Interferons
  • Myelodysplastic Syndromes
  • Polyethylene Glycols
  • Thrombocytosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: